Estimation of Gestational Age by TCD

Sponsor
Aljazeera Hospital (Other)
Overall Status
Unknown status
CT.gov ID
NCT03732937
Collaborator
National Research Centre, Egypt (Other)
700
1
6.1
115.2

Study Details

Study Description

Brief Summary

  • Different parameters are used to estimate gestational age AC, HC , BPD and FL
Condition or Disease Intervention/Treatment Phase
  • Diagnostic Test: Ultrasonography

Detailed Description

-TCD is one of the parameters ,here we are testing its accuracy in calculating GA

Study Design

Study Type:
Observational [Patient Registry]
Anticipated Enrollment :
700 participants
Observational Model:
Case-Control
Time Perspective:
Prospective
Official Title:
Estimation of Gestational Age by Transcerebellar Diameter in Normal and Abnormal Pregnancy States
Actual Study Start Date :
Nov 16, 2018
Anticipated Primary Completion Date :
May 1, 2019
Anticipated Study Completion Date :
May 20, 2019

Arms and Interventions

Arm Intervention/Treatment
Control group

Pregnant ladies with no medical disorders from 16 weeks till term

Diagnostic Test: Ultrasonography
Ultrasonography with biometry and TCD measurement

case group

Pregnant ladies with medical disorders from 16 weeks till term

Diagnostic Test: Ultrasonography
Ultrasonography with biometry and TCD measurement

Outcome Measures

Primary Outcome Measures

  1. The number of participants who will be exactly dated by TCD in comparison to LMP [within 4 months]

    The number of participants who will be exactly dated by TCD in comparison to LMP in weeks

Eligibility Criteria

Criteria

Ages Eligible for Study:
19 Years to 42 Years
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • pregnant ladies with GA between 16 - 40 weeks
Exclusion Criteria:
  • pregnant ladies with GA less than 16 weeks

Contacts and Locations

Locations

Site City State Country Postal Code
1 Algazeerah and Kasralainy hospital Giza Egypt

Sponsors and Collaborators

  • Aljazeera Hospital
  • National Research Centre, Egypt

Investigators

  • Principal Investigator: Mahmoud Alalfy, PhD, Algazeerah hospital -Location (Giza -Egypt ) and National Research centre egypt

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Mahmoud Alalfy, Lecturer, Researcher , National Research centre and Consultant of Obstetrics and Gynecology in Aljazeerah hospital, Aljazeera Hospital
ClinicalTrials.gov Identifier:
NCT03732937
Other Study ID Numbers:
  • cerebellum
First Posted:
Nov 7, 2018
Last Update Posted:
Jan 9, 2019
Last Verified:
Jan 1, 2019
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No

Study Results

No Results Posted as of Jan 9, 2019